Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
TG-1801
TG THERAPEUTICS, INC.
CLL
1 trial -
TGI-5
TG THERAPEUTICS, INC.
CRC (Colorectal Cancer)
1 trial -
TGI-6 Injection
TG THERAPEUTICS, INC.
Advanced or Metastatic Solid Tumors
1 trial -
TGR-1202
TG THERAPEUTICS, INC.
Non-Hodgkin's Lymphoma
1 trial -
TGR-1202
TG THERAPEUTICS, INC.
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
1 trial -
TGR-1202
TG THERAPEUTICS, INC.
Pancreatic Cancer
1 trial -
TGR-1202 + Obinutuzumab + Chlorambucil
TG THERAPEUTICS, INC.
Chronic Lymphocytic Leukemia
1 trial -
TGR-1202 + brentuximab vedotin
TG THERAPEUTICS, INC.
Hodgkin's Lymphoma
1 trial -
TH1902
WINDTREE THERAPEUTICS INC /DE/
Solid Tumor
1 trial -
TIL
Iovance Biotherapeutics B.V.
Sarcoma
1 trial -
TN-401
Tenaya Therapeutics
Arrhythmogenic Right Ventricular Cardiomyopathy
1 trial -
TPST-1495 twice daily
Tempest Therapeutics
Solid Tumor
1 trial -
TRK-100STP (BERASUS LA)
Astellas Pharma Inc
Healthy
1 trial -
TRU-016
Aptevo Therapeutics
B-cell Small Lymphocytic Lymphoma Recurrent
1 trial -
TRU-016 (anti-CD37 protein therapeutic)
Aptevo Therapeutics
Chronic Lymphocytic Leukemia (CLL)
1 trial -
TSC-204-A0201
TScan Therapeutics
Head and Neck Cancer
1 trial -
TTI-101
Tvardi Therapeutics
Pancreatic Cancer
1 trial -
TTI-101
Tvardi Therapeutics
Breast Cancer
2 trials -
TTP4000
vTv Therapeutics
Alzheimer's Disease
1 trial -
TTP607
vTv Therapeutics
Advanced Cancers
1 trial -
TTX-MC138-NODAGA-Cu64
Transcode Therapeutics
Advanced Solid Tumor
1 trial -
Talabostat Mesylate
BioXcel Therapeutics
Cancer of Pancreas
1 trial -
Tcrx T cell
TScan Therapeutics
Gastric Cancer
1 trial -
Tebipenem Pivoxil Hydrobromide
Spero Therapeutics
Diabetes
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources